Skip to content
10-K

Annual Report

Royalty Pharma plc RPRX

0001802768-26-000003

← back to feed
Filed
Feb 11, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 564.46M sh
Shares Diluted FY 2025 · Dec 31, 2024 594.11M sh
Shares Diluted FY 2025 · Dec 31, 2023 602.9M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $1.23B
Stock Repurchased FY 2025 · Dec 31, 2024 $229.65M
Stock Repurchased FY 2025 · Dec 31, 2023 $304.76M
Operating Cash Flow FY 2025 · Dec 31, 2025 $2.49B
Operating Cash Flow FY 2025 · Dec 31, 2024 $2.77B
Operating Cash Flow FY 2025 · Dec 31, 2023 $2.99B
Long Term Debt FY 2025 · Dec 31, 2025 $8.57B
Long Term Debt FY 2025 · Dec 31, 2024 $6.61B
Short Term Debt FY 2025 · Dec 31, 2025 $380M
Short Term Debt FY 2025 · Dec 31, 2024 $997.77M
Cash And Equivalents FY 2025 · Dec 31, 2025 $618.7M
Cash And Equivalents FY 2025 · Dec 31, 2024 $929.03M
Stockholders Equity FY 2025 · Dec 31, 2025 $9.71B
Stockholders Equity FY 2025 · Dec 31, 2024 $10.34B
Stockholders Equity FY 2025 · Dec 31, 2023 $10.08B
Stockholders Equity FY 2025 · Dec 31, 2022 $9.53B
Current Liabilities FY 2025 · Dec 31, 2025 $636.21M
Current Liabilities FY 2025 · Dec 31, 2024 $1.25B
Total Liabilities FY 2025 · Dec 31, 2025 $9.91B
Total Liabilities FY 2025 · Dec 31, 2024 $7.88B
Current Assets FY 2025 · Dec 31, 2025 $1.53B
Current Assets FY 2025 · Dec 31, 2024 $1.8B
Total Assets FY 2025 · Dec 31, 2025 $19.62B
Total Assets FY 2025 · Dec 31, 2024 $18.22B
Eps Diluted FY 2025 · Dec 31, 2025 $1.78
Eps Diluted FY 2025 · Dec 31, 2024 $1.91
Eps Diluted FY 2025 · Dec 31, 2023 $2.53
Eps Basic FY 2025 · Dec 31, 2025 $1.79
Eps Basic FY 2025 · Dec 31, 2024 $1.92
Eps Basic FY 2025 · Dec 31, 2023 $2.54
Sga Expense FY 2025 · Dec 31, 2025 $573.48M
Sga Expense FY 2025 · Dec 31, 2024 $236.67M
Sga Expense FY 2025 · Dec 31, 2023 $249.75M
Rd Expense FY 2025 · Dec 31, 2025 $452M
Rd Expense FY 2025 · Dec 31, 2024 $2M
Rd Expense FY 2025 · Dec 31, 2023 $52M
Net Income FY 2025 · Dec 31, 2025 $770.95M
Net Income FY 2025 · Dec 31, 2024 $858.98M
Net Income FY 2025 · Dec 31, 2023 $1.13B
Operating Income FY 2025 · Dec 31, 2025 $1.56B
Operating Income FY 2025 · Dec 31, 2024 $1.29B
Operating Income FY 2025 · Dec 31, 2023 $1.49B
Revenue FY 2025 · Dec 31, 2025 $2.38B
Revenue FY 2025 · Dec 31, 2024 $2.26B
Revenue FY 2025 · Dec 31, 2023 $2.35B